LLY

1,034.66

-2.08%↓

JNJ

205.59

+1.04%↑

ABBV

229.43

+2.73%↑

UNH

336.82

+3.99%↑

AZN

90.8

+0.33%↑

LLY

1,034.66

-2.08%↓

JNJ

205.59

+1.04%↑

ABBV

229.43

+2.73%↑

UNH

336.82

+3.99%↑

AZN

90.8

+0.33%↑

LLY

1,034.66

-2.08%↓

JNJ

205.59

+1.04%↑

ABBV

229.43

+2.73%↑

UNH

336.82

+3.99%↑

AZN

90.8

+0.33%↑

LLY

1,034.66

-2.08%↓

JNJ

205.59

+1.04%↑

ABBV

229.43

+2.73%↑

UNH

336.82

+3.99%↑

AZN

90.8

+0.33%↑

LLY

1,034.66

-2.08%↓

JNJ

205.59

+1.04%↑

ABBV

229.43

+2.73%↑

UNH

336.82

+3.99%↑

AZN

90.8

+0.33%↑

Search

Globus Medical Inc (Class A)

Abrir

SetorSaúde

88.97 0.24

Visão Geral

Variação de preço das ações

24h

Atual

Mín

88.45

Máximo

89.79

Indicadores-chave

By Trading Economics

Rendimento

-84M

119M

Vendas

24M

769M

P/E

Médio do Setor

29.058

79.874

EPS

1.18

Margem de lucro

15.469

Funcionários

5,300

EBITDA

22M

215M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+3.58% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

3.9B

12B

Abertura anterior

88.73

Fecho anterior

88.97

Sentimento de Notícias

By Acuity

50%

50%

162 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Globus Medical Inc (Class A) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

2 de dez. de 2025, 17:29 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

2 de dez. de 2025, 16:21 UTC

Ganhos

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

2 de dez. de 2025, 16:18 UTC

Ganhos

Correction to Scotiabank Quarterly Earnings Buoyed Article

2 de dez. de 2025, 23:53 UTC

Conversa de Mercado

Nikkei May Rise After Gains on Wall Street -- Market Talk

2 de dez. de 2025, 22:48 UTC

Ganhos

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

2 de dez. de 2025, 22:12 UTC

Conversa de Mercado

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

2 de dez. de 2025, 22:03 UTC

Conversa de Mercado

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

2 de dez. de 2025, 22:00 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

2 de dez. de 2025, 22:00 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

2 de dez. de 2025, 22:00 UTC

Conversa de Mercado

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

2 de dez. de 2025, 21:56 UTC

Ganhos

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

2 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

2 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

2 de dez. de 2025, 21:44 UTC

Ganhos

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 de dez. de 2025, 21:38 UTC

Conversa de Mercado

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

2 de dez. de 2025, 21:19 UTC

Ganhos

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 de dez. de 2025, 20:06 UTC

Conversa de Mercado

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

2 de dez. de 2025, 19:55 UTC

Conversa de Mercado

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

2 de dez. de 2025, 19:53 UTC

Conversa de Mercado
Ganhos

Global Equities Roundup: Market Talk

2 de dez. de 2025, 19:53 UTC

Conversa de Mercado
Ganhos

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

2 de dez. de 2025, 19:24 UTC

Conversa de Mercado

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

2 de dez. de 2025, 19:06 UTC

Conversa de Mercado

Precious Metals Step Back After Silver Sets Record -- Market Talk

2 de dez. de 2025, 18:27 UTC

Aquisições, Fusões, Aquisições de Empresas

Kraken to Acquire Backed Finance AG

2 de dez. de 2025, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

2 de dez. de 2025, 17:20 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

2 de dez. de 2025, 15:17 UTC

Conversa de Mercado

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

2 de dez. de 2025, 14:47 UTC

Conversa de Mercado

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

2 de dez. de 2025, 14:38 UTC

Conversa de Mercado

Silver Steps Back From Record Levels -- Market Talk

2 de dez. de 2025, 14:31 UTC

Conversa de Mercado
Ganhos

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

Comparação entre Pares

Variação de preço

Globus Medical Inc (Class A) Previsão

Preço-alvo

By TipRanks

3.58% parte superior

Previsão para 12 meses

Média 93 USD  3.58%

Máximo 114 USD

Mínimo 64 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para Globus Medical Inc (Class A) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

12 ratings

9

Comprar

3

Manter

0

Vender

Pontuação Técnica

By Trading Central

72.18 / 73.07Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

162 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat